Not finding it? Sign in to also search OpenAlex live.
-
343 Identification of tumor-reactive T cells targeting melanoma Dark Antigens™ validates this novel class of targets for development of immunotherapies2022 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Tom Hofland, Thomas Morgan Hulen, Elizabeth Verdegaal, Joseph D. Dukes, Shawez Khan, Pita de Kok, +9 more
1citations
1 result